Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer

1 Guidance

2 Clinical need and practice

3 The technologies

4 Evidence and interpretation

5 Implementation

6 Recommendations for further research

7 Related guidance

8 Review of guidance

Appendix A. Appraisal Committee members and NICE project team

Appendix B. Sources of evidence considered by the Committee

Changes after publication

About this guidance

Select chapters and save as Word or PDF documents to print or share